Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer.
- DOI
- 10.1016/s0959-8049(01)00321-5
- Published
- 2001 Dec
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0959-8049-01-00321-5,
title = {Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer.},
author = {Alonso V and Escudero P and Zorrilla M and Isla MD and Herrero A and Mayordomo JI and Martinez-Trufero J and Sáenz A and Tres A and Antón A},
year = {2001},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/s0959-8049(01)00321-5},
url = {https://doi.org/10.1016/s0959-8049(01)00321-5}
}RIS
TY - JOUR TI - Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer. AU - Alonso V AU - Escudero P AU - Zorrilla M AU - Isla MD AU - Herrero A AU - Mayordomo JI AU - Martinez-Trufero J AU - Sáenz A AU - Tres A AU - Antón A PY - 2001 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/s0959-8049(01)00321-5 UR - https://doi.org/10.1016/s0959-8049(01)00321-5 ER -
APA
V, A., P, E., M, Z., MD, I., A, H., JI, M., J, M., A, S., A, T., & A, A. (2001). Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/s0959-8049(01)00321-5
Source records
- pubmed · retrieved 2026-09-25T15:19:01.038Z
- europe-pmc · retrieved 2026-09-25T15:19:01.064Z